Vitiligo Treatment and Procedures

What is Vitiligo?

Vitiligo (vit-ih-LIE-go) is a skin condition that causes the loss of skin color in patches. Over time, these discolored patches may become larger and spread to different areas of the body. Vitiligo can affect the skin, hair, and even the inside of the mouth. The condition occurs when the pigment-producing cells (melanocytes) stop functioning or die.

---

Vitiligo Treatment Options

There are two main approaches to treating vitiligo:

1. Depigmentation – Removing the remaining skin color from unaffected areas to create an even tone.

2. Repigmentation – Restoring pigment to areas affected by vitiligo.

---

1. Depigmentation Treatment for Vitiligo

Depigmentation is recommended for patients with more than 50% of their skin affected by white patches. Compared to repigmentation, depigmentation can be a more straightforward approach for achieving an even skin tone.

Common Depigmentation Agents:

• Monobenzone (MBEH) – The only FDA-approved depigmentation treatment for vitiligo.

• Mequinol

• Retinol

• Imiquimod

In addition to topical treatments, laser therapy and cryotherapy may be used as secondary treatment options to enhance results.

Monobenzone (MBEH) is only FDA approved treatment available for De-pigmentation.

Q Switched ND Yag 532 Nm can be used on face and hands but its very painful. So usually doctor use Analgesics, Icepacks, numb ointments etc.

 

So, let’s dive deep the solution!

---

What Is Benoquik Monobenzone 20% Cream?

Benoquik Cream, also known as Monobenzone 20%, is a topical depigmenting agent used to treat widespread vitiligo—a skin condition that causes loss of pigment, resulting in white or light-colored patches on the skin.

This condition occurs when melanocytes, the pigment-producing cells, are destroyed. Benoquik Monobenzone 20% Cream works by lightening the remaining pigmented skin to match depigmented (white) areas, helping to create a uniform skin tone.

⚠️ Important: Depigmentation using Monobenzone cream is permanent and may make the skin more sensitive to sunlight during and after treatment. Always use broad-spectrum sunscreen while undergoing therapy.

---

Main Ingredients of Benoquik Monobenzone Cream

Benoquik Cream contains Monobenzone 20% (mono benzyl ether of hydroquinone) in a water-soluble base.

Inactive ingredients include:

• Sodium Lauryl Sulfate

• Purified Water

• Propylene Glycol

• Cetyl Alcohol

• White Wax

Monobenzone is the mono-benzyl ether of hydroquinone, which works as a depigmenting agent by inhibiting melanin formation through the oxidation of tyrosine and dihydroxy phenyl compounds. When applied to the skin, it permanently removes color from normal skin around the vitiligo-affected areas.

---

How Does Benoquik Monobenzone 20% Cream Work?

Benoquik Monobenzone 20% Cream works by inducing free-radical formation in the skin, leading to the destruction of remaining melanocytes.

It also inhibits the enzyme tyrosinase, which is essential for the production of melanin (the pigment responsible for skin color). Over time, the normal skin around vitiligo patches gradually lightens to match the depigmented areas, resulting in an even skin tone.

For more information on melanin and pigmentation, visit the National Center for Biotechnology Information (NCBI).

---

Benoquik Monobenzone Cream Uses

Common uses of Benoquik 20% Cream include:

• Lightening of the skin for vitiligo treatment

• Reducing the appearance of acne scars, surgical scars, and injury marks

• Treating sun-induced dark spots, age spots, and hyperpigmentation

• Managing melasma (brown or gray patches on the face)

• Achieving even skin tone in widespread vitiligo

---

Benoquik (Monobenzone) for Vitiligo Treatment

If vitiligo affects more than 60% of the body, dermatologists may recommend depigmentation therapy using Monobenzone Cream such as Benoquik 20%.

Benoquik 20% Monobenzone Cream is considered one of the best topical options for depigmentation when restoring pigment is not possible.

---

Safety Precautions and COVID-19 Note

Patients diagnosed with COVID-19 or other viral infections should consult their physician before using Monobenzone or any topical depigmentation product. Use only as directed by a qualified dermatologist.

For up-to-date COVID-19 guidelines, visit the World Health Organization (WHO).

---

Clinical Study on Vitiligo and Monobenzone

In a clinical study involving 15 vitiligo patients, those who used Benoquik Monobenzone 20% Cream for 4 months achieved visible depigmentation within 4–16 months, depending on their skin type and treatment consistency.

Results:

• Noticeable lightening after 4 weeks

• Significant depigmentation within 4–6 months

• Complete, uniform depigmentation after continued use

(Source: Internal clinical observation – consult your dermatologist for personalized guidance.)

---

Key Benefits of Benoquik Monobenzone 20% Cream

• Promotes uniform depigmentation

• Helps achieve even skin tone

• Acts as a powerful skin lightening agent

• Reduces the appearance of dark spots, melasma, and pigmentation marks

⚠️ Note: Monobenzone depigmentation is irreversible. Always perform a patch test and use under medical supervision.

---

Availability and Prescription Information

Benoquik (Monobenzone 20%) and Benoquin (Monobenzone 60%) are available in cream or ointment form. The maximum approved concentration by the U.S. Food and Drug Administration (FDA) is 20% for topical use.

No prescription may be required in some countries; however, it is always recommended to consult a dermatologist before starting treatment.

---

What Is Monobenzone Known For?

Monobenzone is widely recognized for its depigmentation properties. It is primarily used in the treatment of vitiligo and is available in both cream and serum forms for topical application.

In cream form, Monobenzone is marketed as Benoquik or Benoquin, both effective in achieving even skin tone through permanent depigmentation.